Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Amorphization in pharmaceutical technology].

Piroska Révész1, Orsolya Laczkovich, István Eros

  • 1Szegedi Tudományegyetem, Gyógyszertechnológiai Intézet, Szeged, Eötvös u. 6. - 6720.

Acta Pharmaceutica Hungarica
|November 5, 2004
PubMed
Summary

This article explains how to convert crystalline drug substances into amorphous forms using established pharmaceutical methods. The authors describe three approaches: solvent-based techniques, hot-melt processing, and milling. Each method has specific conditions and limitations. The goal is to help professionals choose the most suitable amorphization technique for their needs. The study does not introduce new methods but organizes existing ones for clarity. The authors suggest that amorphization can improve drug solubility and manufacturability. The study concludes that amorphization is a valuable tool in pharmaceutical technology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formulation optimization of sustained-release ammonio methacrylate copolymer microspheres. Effects of log p and concentration of polar cosolvents, and role of the drug/copolymer ratio.

Pharmaceutics·2013
Same author

Intranasal delivery of human beta-amyloid peptide in rats: effective brain targeting.

Cellular and molecular neurobiology·2009
Same author

Permeability of human amniotic membrane to ofloxacin in vitro.

Investigative ophthalmology & visual science·2009
Same author

Study of gel-forming properties of sucrose esters for thermosensitive drug delivery systems.

International journal of pharmaceutics·2009
Same author

Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2008
Same author

Evaluation of the binding effect of human serum albumin on the properties of granules.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2008

Area of Science:

  • Pharmaceutical technology
  • Drug formulation science
  • Material processing in pharmacology

Background:

Pharmaceutical development often encounters challenges when working with crystalline drug substances. These challenges include the presence of multiple polymorphic forms, which can affect drug stability and performance. Additionally, some active pharmaceutical ingredients exhibit poor solubility in water, complicating their formulation into effective dosage forms. Crystalline materials can also be difficult to process during manufacturing, leading to inefficiencies in production. Patenting new drug forms is another driver for innovation in drug development. Prior research has shown that amorphous forms can enhance solubility and bioavailability. However, the transition from crystalline to amorphous states requires specific techniques. No prior work had resolved the best methods for amorphization in a practical context. This gap motivated the exploration of established pharmaceutical protocols. The need for accessible protocols led to the development of this review.

Purpose Of The Study:

Keywords:
Amorphous drug formsPharmaceutical processing methodsDrug solubility enhancementHot-melt amorphization

Frequently Asked Questions

The study introduces three established methods for amorphization: solvent methods, hot-melt technologies, and milling procedures.

Amorphization can improve drug solubility, overcome polymorphism issues, and simplify processing of crystalline materials.

The hot-melt method uses thermal energy to melt the drug material and form an amorphous solid.

Milling applies mechanical forces to break down crystalline structures into an amorphous form.

Solvent methods dissolve the drug material and then remove the solvent to form an amorphous solid.

Related Experiment Videos

This study aims to present practical approaches for converting crystalline drug substances into amorphous forms. The authors focus on methods that are already part of pharmaceutical technology. The specific problem addressed is the selection of appropriate amorphization techniques. The motivation stems from the need to improve drug solubility and manufacturability. The study also considers the legal and commercial implications of amorphous drug forms. The goal is to provide a guide for professionals in the field. The authors propose that these methods can be integrated into existing workflows. The study does not introduce new techniques but organizes existing ones for clarity.

Main Methods:

The authors describe three primary methods for amorphization. The first involves solvent-based techniques, which are commonly used in pharmaceutical processing. The second method is hot-melt processing, which relies on thermal energy to disrupt crystallinity. The third approach is milling, which physically breaks down crystalline structures. Each method is explained in terms of its application and limitations. The protocols are based on established practices in the industry. The authors do not propose new variations but summarize existing procedures. The methods are presented with an emphasis on practical implementation. The goal is to help practitioners choose the most suitable method for their needs.

Main Results:

The study outlines three distinct amorphization routes. Solvent methods involve dissolving the drug and then removing the solvent. Hot-melt technologies use heat to melt the drug and form an amorphous solid. Milling procedures rely on mechanical forces to break down crystalline structures. Each method has specific conditions for successful amorphization. The authors do not claim one method is superior to the others. Instead, they highlight the contexts in which each method is most effective. The results include a comparison of the advantages and limitations of each route. The authors suggest that the choice of method depends on the drug's properties and the desired outcome.

Conclusions:

The authors conclude that amorphization is a viable strategy for improving drug solubility and manufacturability. They emphasize that the choice of method depends on the drug's characteristics and the available resources. The study does not propose new methods but organizes existing ones for practical use. The authors suggest that practitioners can benefit from understanding the strengths and limitations of each approach. The study does not claim that one method is universally better than the others. Instead, it provides a framework for selecting the most appropriate technique. The authors propose that these methods can be adapted to different drug development scenarios. The study concludes that amorphization is a valuable tool in pharmaceutical technology.

The authors suggest that the choice of method depends on the drug's properties and the desired outcome.